NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

BioLineRx Ltd (TA: BLRX)

 
BLRX Technical Analysis
5
As on 30th Mar 2025 BLRX STOCK Price closed @ 1.90 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 26.87 & Strong Sell for SHORT-TERM with Stoploss of 39.45 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

BLRXSTOCK Price

Open 1.80 Change Price %
High 1.90 1 Day -0.10 -5.00
Low 1.80 1 Week -0.10 -5.00
Close 1.90 1 Month -0.40 -17.39
Volume 12130546 1 Year -41.30 -95.60
52 Week High 43.50 | 52 Week Low 1.80
 
TA Israel Most Active Stocks
TA125 2008.05 1.06%
BLRX 1.90 -5.00%
DSCT 2607.00 1.24%
CANF 1.90 0.00%
FRSX 8.60 -5.49%
BEZQ 548.90 0.72%
MVNE 973.50 0.34%
TDGN-L 171.50 17.55%
LUMI 5038.00 -0.16%
ISRA-L 1.30 -0.76%
 
TA Israel Top Gainers Stocks
PLAZ 134.30 49.39%
PLAZ 134.30 49.39%
TDGN-L 171.50 17.55%
BRMG 2105.00 17.01%
MCTC 103.00 11.96%
CNMD 45.10 10.54%
CNMD 45.10 10.54%
SFET 65.10 8.50%
SFET 65.10 8.50%
GOHO 2802.00 8.44%
 
TA Israel Top Losers Stocks
KMNK 51.00 -23.19%
BCNV 20010.00 -19.48%
ULTR 74.10 -16.74%
MEAT 0.77 -9.41%
MEAT 0.77 -9.41%
ININ 227.00 -9.16%
MYSZ 153.90 -8.66%
MYSZ 153.90 -8.66%
PAYT 6310.00 -8.56%
NERZ 510.00 -8.11%
 
 
BLRX
Daily Charts
BLRX
Intraday Charts
Whats New @
Bazaartrend
BLRX
Free Analysis
 
BLRX Important Levels Intraday
RESISTANCE2.09
RESISTANCE2.03
RESISTANCE1.99
RESISTANCE1.95
SUPPORT1.85
SUPPORT1.81
SUPPORT1.77
SUPPORT1.71
 
BLRX Forecast March 2025
4th UP Forecast16.35
3rd UP Forecast11.72
2nd UP Forecast8.85
1st UP Forecast5.99
1st DOWN Forecast-2.19
2nd DOWN Forecast-5.05
3rd DOWN Forecast-7.92
4th DOWN Forecast-12.55
 
BLRX Weekly Forecast
4th UP Forecast14.04
3rd UP Forecast10.15
2nd UP Forecast7.74
1st UP Forecast5.33
1st DOWN Forecast-1.53
2nd DOWN Forecast-3.94
3rd DOWN Forecast-6.35
4th DOWN Forecast-10.24
 
BLRX Forecast2025
4th UP Forecast83.22
3rd UP Forecast57.14
2nd UP Forecast41.02
1st UP Forecast24.9
1st DOWN Forecast-21.1
2nd DOWN Forecast-37.22
3rd DOWN Forecast-53.34
4th DOWN Forecast-79.42
 
 
BLRX Other Details
Segment EQ
Market Capital 42568679424.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
BLRX Address
BLRX
 
BLRX Latest News
 
Your Comments and Response on BioLineRx Ltd
 
BLRX Business Profile
BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. Its development pipeline consists of clinical-stage therapeutic candidates, which include BL-8040, a peptide for the treatment of solid tumors, hematological malignancies, and stem cell mobilization; AGI-134, an immuno-oncology agent in the development for solid tumors; and BL-5010, a customized, proprietary, pen-like applicator for the non-surgical removal of skin lesions. The company has collaboration agreement with MSD for the cancer immunotherapy field; MD Anderson Cancer Center to investigate the combination of BL-8040 with KEYTRUDA (pembrolizumab) in pancreatic cancer; and Genentech Inc. to investigate the combination of BL-8040 for solid tumors. BioLineRx Ltd. was founded in 2003 and is headquartered in Hevel Modi'in, Israel. Address: Modi?in Technology Park, Hevel Modi'in, Israel, 7177871
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service